From August 23, 2022 to September 30, 2022, the company has repurchased 242,411 shares, representing 0.29% for $1.17 million. With this, the company has completed the repurchase of 242,411 shares, representing 0.29% for $1.17 million under the buyback announced on August 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -4.60% | -5.14% | -12.63% |
04-18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
04-15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.63% | 134M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- Tranche Update on I-Mab's Equity Buyback Plan announced on August 30, 2022.